SSA
GILD icon

Shepherd Street Advisors’s Gilead Sciences GILD Stock Holding History

Shepherd Street Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
7,812
+1,344
+21% +$177K 0.9% 34
2026
Q1 		$901K Buy
6,468
+2,116
+49% +$296K 0.89% 36
2025
Q4 		$534K Buy
+4,352
New +$529K 0.51% 54

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Shepherd Street Advisors's GILD Position: Q2 2026 in Review

Shepherd Street Advisors increased its Gilead Sciences (GILD) stake by 21% in Q2 2026, buying an estimated $177K and bringing the position to 7,812 shares worth $1.03M. The position accounts for 0.9% of the portfolio, ranked #34.

Shepherd Street Advisors first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Shepherd Street Advisors held 7,812 shares of Gilead Sciences worth $1.03M as of Q2 2026.
  • Shepherd Street Advisors bought 1,344 Gilead Sciences shares in Q2 2026, an estimated $177K.
  • Gilead Sciences made up 0.9% of Shepherd Street Advisors's portfolio in Q2 2026, its #34 holding.
  • Shepherd Street Advisors first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Shepherd Street Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.